Brenton Scott
Fondateur chez Pulmotect, Inc.
Fortune : 5 M $ au 31/05/2024
Profil
Brenton Scott has founded two companies, Bondwell Technologies, Inc. in 2017 and Pulmotect, Inc. in 2007, where he holds the title of President & Chief Operating Officer.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/02/2023 | 21 185 283 ( 25,41% ) | 5 M $ | 31/05/2024 |
Postes actifs de Brenton Scott
| Sociétés | Poste | Début |
|---|---|---|
Pulmotect, Inc.
 Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Fondateur | 01/01/2007 |
Anciens postes connus de Brenton Scott
| Sociétés | Poste | Fin |
|---|---|---|
Bondwell Technologies, Inc.
 Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Health Technology |
Bondwell Technologies, Inc.
Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Health Technology |
